
    
      The study drug (loading dose) is administered at least 1 hour before catheterization for
      diagnostic imaging or percutaneous coronary interventions (PCI). The incidence of bleeding is
      thought to be an important index to assess the safety of this drug, therefore thrombolysis in
      myocardial infarction (TIMI) is evaluated.
    
  